期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

关注肥胖与糖尿病相关性及其潜在机制 被引量：8

原文传递
导出
摘要 随着生活方式和饮食习惯的改变，肥胖和糖尿病近年来呈快速流行的趋势。本文就肥胖与糖尿病相关性及其潜在机制进行评述。
作者 洪天配 魏蕊
机构地区 北京大学第三医院内分泌科
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第36期2849-2850,共2页 National Medical Journal of China
基金 国家重点基础研究发展计划（973计划）（2012CB517502）
关键词 糖尿病 相关性 肥胖 饮食习惯 生活方式
分类号 R589.2 [医药卫生—内分泌] R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献14

  • 1Langenberg C, Sharp SJ, Schulze MB, et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med, 2012, 9 :e1001230.
  • 2王娇,张如意,陈容平,陈立曙,林少达,梁干雄,胡宝春,朱志章,王玉磷,严励,林健才,李延兵,蔡德鸿.广东省超重肥胖2型糖尿病患者血脂异常患病率及危险因素分析[J].中华医学杂志,2013,93(36):2851-2856. 被引量：22
  • 3Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study : a 20-year follow-up study. Lancet, 2008, 371 : 1783 -1789.
  • 4Knowler WC, Fowler SE, Hamman RF, et al. 10-year fi llow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet, 2009, 374 : 1677-1686.
  • 5Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med, 2010,170 : 1566-1575.
  • 6Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 2004, 27:155-161.
  • 7Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults ( CONQUER ) : a randomised, placebo-controlled, phase 3 trial. Lancet, 2011, 377 : 1341-1352.
  • 8O'Neil PM, Smith SR, Weissman NJ, et al. Randomized placebo- controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring), 2012, 20:1426-1436.
  • 9Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med, 2012, 366 : 1577-1585.
  • 10Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med, 2012, 366 : 1567-1576.

二级参考文献38

  • 1阴津华,黎明,杨莆,吴从愿.人网膜前脂肪细胞原代培养及其生物学特性研究[J].中华医学杂志,2007,87(12):838-841. 被引量：9
  • 2叶平,孙晓楠.高血压与血脂异常[J].中国实用内科杂志,2007,27(12):914-916. 被引量：17
  • 3方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量：3067
  • 4lmai S, Armstrong CM, Kaeberlein M, et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature, 2000, 403:795-800.
  • 5Blander G, Guarente L. The Sir2 family of protein deaeetylases. Annu Rev Biochem, 2004, 73:417-435.
  • 6Bordone L, Guarentc L. Calorie restriction, SIRTI and metabolism: understanding longevity. Nat Rev Mol Cell Biol, 2005, 6:298-305.
  • 7Picard F, Kurte ' M, Chung N, el al. Sirtl promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature, 2004, 429:771-776.
  • 8Qiao L, Shao J. SIRTI regulates adiponectin gene expression through Foxol-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem, 2006, 281:39915-39924.
  • 9Gillum MP, Kotas ME, Erion DM, et al. SirTl regulates adipose tissue inflammation. Diabetes, 2011, 60:3235-3245.
  • 10Haigis MC, Sinclair DA. Mmnmalian sirtuins: biological insights and disease relevance. Annu Rev Pathol, 2010, 5:253-295.

共引文献27

同被引文献101

引证文献8

二级引证文献96

中华医学杂志
2013年 第36期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部